Podcast
 |
| Jerry Flanagan, healthcare policy director for ConsumerWatchdog, discusses his group’s lawsuit against Anthem Blue Cross of California over its rate hikes, what they mean for healthcare reform, and why the proposed healthcare legislation wouldn’t have prevented Anthem from instituting the rate increases in the first place. |
G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech posts gain in February as broader markets strengthen March 03, 2010 | Press Release
Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release
Biotech Closes the Year on an Upswing January 04, 2010 | Press Release
See all News
Greg B. Young
DirectorGreg B. Young joined Burrill & Company in 2000 and has been primarily involved in sourcing and evaluating new business opportunities as part of the firm's venture activities. His focus areas of investment cover renewable chemicals and energy, as well as biotechnologies enabling sustainability. Mr. Young acts as an investment manager for the Malaysian Life Sciences Capital Fund, a venture fund co-managed by Burrill & Company.
Mr. Young currently serves on the Board of HCL Cleantech and is a Board Observer on the Boards of The Brand Accelerator, Gevo and Glori Oil.
Prior to joining Burrill & Company, Mr. Young worked as a molecular biologist focused on protein expression at an early-stage biotech company located in San Diego. Mr. Young received his BS in Biochemistry and Cell Biology from the University of California, San Diego and an MS in Biotechnology and Business from Northwestern University.